|Grant ID: R1108|
Recruitment of Rising Stars
Novartis Institutes for Biomedical Research
March 24, 2011
The genomes inside cancer cells nearly always contain genetic mutations or alternations in their DNA sequence. Now it is becoming more and more evident that changes in gene expression that don’t involve changing the DNA sequence itself —called “epigenetics”— are also important in cancer.
Molecular biologist Taiping Chen is trying to understand the mechanisms and importance of epigenetic changes during cancer initiation and progression, at the University of Texas MD Anderson Cancer Center, Science Park campus in Smithville. Chen was recruited in 2011, with the help of a Rising Stars Award from CPRIT, to the department of epigenetics and molecular carcinogenesis. He was a researcher at the Novartis Institutes for Biomedical Research in Cambridge, Mass.